These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


292 related items for PubMed ID: 11884403

  • 1. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts.
    Vermes C, Jacobs JJ, Zhang J, Firneisz G, Roebuck KA, Glant TT.
    J Biol Chem; 2002 May 10; 277(19):16879-87. PubMed ID: 11884403
    [Abstract] [Full Text] [Related]

  • 2. Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells.
    Erices A, Conget P, Rojas C, Minguell JJ.
    Exp Cell Res; 2002 Oct 15; 280(1):24-32. PubMed ID: 12372336
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors.
    Kimura T, Sakabe H, Tanimukai S, Abe T, Urata Y, Yasukawa K, Okano A, Taga T, Sugiyama H, Kishimoto T, Sonoda Y.
    Blood; 1997 Dec 15; 90(12):4767-78. PubMed ID: 9389693
    [Abstract] [Full Text] [Related]

  • 4. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
    Jostock T, Müllberg J, Ozbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath MF, Rose-John S.
    Eur J Biochem; 2001 Jan 15; 268(1):160-7. PubMed ID: 11121117
    [Abstract] [Full Text] [Related]

  • 5. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production.
    Igaz P, Horváth A, Horváth B, Szalai C, Pállinger E, Rajnavölgyi E, Tóth S, Rose-John S, Falus A.
    Immunol Lett; 2000 Mar 01; 71(3):143-8. PubMed ID: 10722865
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures.
    Franchimont N, Durant D, Canalis E.
    Endocrinology; 1997 Aug 01; 138(8):3380-6. PubMed ID: 9231791
    [Abstract] [Full Text] [Related]

  • 7. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G, Küster A, Hemmann U, Keul R, Horsten U, Martens A, Graeve L, Wijdenes J, Heinrich PC.
    J Immunol; 1998 Dec 01; 161(11):6347-55. PubMed ID: 9834125
    [Abstract] [Full Text] [Related]

  • 8. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K, Taga T, Kishimoto T, Nakamura S.
    Int Immunol; 1996 Apr 01; 8(4):595-602. PubMed ID: 8722639
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage.
    Taguchi Y, Yamamoto M, Yamate T, Lin SC, Mocharla H, DeTogni P, Nakayama N, Boyce BF, Abe E, Manolagas SC.
    Proc Assoc Am Physicians; 1998 Apr 01; 110(6):559-74. PubMed ID: 9824538
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.
    Gaillard JP, Mani JC, Liautard J, Klein B, Brochier J.
    Eur Cytokine Netw; 1999 Mar 01; 10(1):43-8. PubMed ID: 10210772
    [Abstract] [Full Text] [Related]

  • 11. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility.
    Sherwin JR, Smith SK, Wilson A, Sharkey AM.
    J Clin Endocrinol Metab; 2002 Aug 01; 87(8):3953-60. PubMed ID: 12161539
    [Abstract] [Full Text] [Related]

  • 12. Synergistic action of Flt3 and gp130 signalings in human hematopoiesis.
    Ebihara Y, Tsuji K, Lyman SD, Sui X, Yoshida M, Muraoka K, Yamada K, Tanaka R, Nakahata T.
    Blood; 1997 Dec 01; 90(11):4363-8. PubMed ID: 9373247
    [Abstract] [Full Text] [Related]

  • 13. GP130 and c-kit signalling, initiated by the sIL-6R/IL-6 complex, is insufficient to expand the primitive adult bone marrow CD34+CD38- pre-CFU cell.
    Van Bockstaele DR, Nijs G, Lenjou M, Bosmans E, Vanham G, Rodrigus I, Berneman ZN.
    Ann Hematol; 2000 Dec 01; 79(12):667-71. PubMed ID: 11195003
    [Abstract] [Full Text] [Related]

  • 14. Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus.
    Aoki Y, Narazaki M, Kishimoto T, Tosato G.
    Blood; 2001 Nov 15; 98(10):3042-9. PubMed ID: 11698289
    [Abstract] [Full Text] [Related]

  • 15. The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone.
    Cho SW, Pirih FQ, Koh AJ, Michalski M, Eber MR, Ritchie K, Sinder B, Oh S, Al-Dujaili SA, Lee J, Kozloff K, Danciu T, Wronski TJ, McCauley LK.
    J Biol Chem; 2013 Mar 08; 288(10):6814-25. PubMed ID: 23297399
    [Abstract] [Full Text] [Related]

  • 16. A complex of the soluble interleukin-6 receptor and interleukin-6 is internalized via the signal transducer gp130.
    Graeve L, Korolenko TA, Hemmann U, Weiergräber O, Dittrich E, Heinrich PC.
    FEBS Lett; 1996 Dec 09; 399(1-2):131-4. PubMed ID: 8980136
    [Abstract] [Full Text] [Related]

  • 17. Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells.
    Nishimura R, Moriyama K, Yasukawa K, Mundy GR, Yoneda T.
    J Bone Miner Res; 1998 May 09; 13(5):777-85. PubMed ID: 9610741
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.
    Nakanishi H, Yoshioka K, Joyama S, Araki N, Myoui A, Ishiguro S, Ueda T, Yoshikawa H, Itoh K.
    Am J Pathol; 2004 Aug 09; 165(2):471-80. PubMed ID: 15277221
    [Abstract] [Full Text] [Related]

  • 19. Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation.
    März P, Herget T, Lang E, Otten U, Rose-John S.
    Eur J Neurosci; 1997 Dec 09; 9(12):2765-73. PubMed ID: 9517481
    [Abstract] [Full Text] [Related]

  • 20. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases.
    Kallen KJ.
    Biochim Biophys Acta; 2002 Nov 11; 1592(3):323-43. PubMed ID: 12421676
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.